Halozyme Therapeutics, Inc. · NASDAQ:HALO
Posard Matthew L. received 3,796 Halozyme Therapeutics, Inc. shares as an award (Form 4)
Traded May 5, 2026 · Filed May 7, 2026
On May 5, 2026, Posard Matthew L. (Director) received 3,796 Halozyme Therapeutics, Inc. shares as an award, leaving 77,835 shares. Filed May 7, 2026 (Form 4).
- Awarded
- 3,796 shares
- Holding after
- 77,835 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Award | 3,796 | 77,835 | Direct |
Source
Related
- Halozyme Therapeutics, Inc.
- Posard Matthew L.
- Halozyme Therapeutics, Inc. shareholders
- Form 4 · Posard Matthew L. · Oct 2, 2026
- Form 4 · Posard Matthew L. · Sep 17, 2026
- Form 4 · Torley Helen · Oct 8, 2026
- Form 4 · Daly James M · Oct 2, 2026
- Form 4 · Torley Helen · Sep 11, 2026
- Form 4 · Appelhans Dannielle · Sep 2, 2026
- Form 4 · Torley Helen · Aug 19, 2026